肝细胞癌合并胆管癌栓的治疗
作者:
通讯作者:
作者单位:

作者简介:

基金项目:


Treatment of hepatocellular carcinoma with bile duct tumor thrombus
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    目的探讨肝细胞癌(HCC)合并胆管癌栓的治疗。方法对1995年1月~2002年12月收治的34例HCC合并胆管癌栓的治疗情况进行回顾性总结和分析。结果34例中1例未予治疗,6例行PTCD, 27例开腹手术。开腹手术术后30d死亡率为22.2%(6/27), 并发症发生率为55.6%(15/27)。16例行肝切除术、胆管取癌栓及胆道引流术病人术后生存时间为1个月~27个月,中位生存期为16.5个月。结论HCC合并胆管癌栓的预后差,但对其早期诊断和扩大手术治疗,是改善此病预后的关键。

    Abstract:

    Objective:To study the treatment of hepatocellular carcinoma(HCC) complicated with bile duct thrombus.Methods:Restrospective study was performed on the treatment of 34 cases of HCC complicated with bile duct tumor thrombus from January 1995 to December 2002 admitted to our hospital.Results:Among the 34 cases, one patient had no treatment,6 cases received PTCD and 27 cases received operation.In surgical treatment patients,the postoperative 30 days mortality was 22.2%(6/27),the morbidity was 55.6%(15/27).In 16 patients who received hepatectomy with thrombectomy and biliary duct drainage, the survival time was 1~27 months with a median survival time of 16.5 months.Conclusion:The prognosis of HCC complicated with bile duct tumor thrombus is poor. Early diagnosis and aggressive operative are the key points to improving the survival time of patients.

    参考文献
    相似文献
    引证文献
引用本文

罗时敏,梁力建,彭宝岗.肝细胞癌合并胆管癌栓的治疗[J].中国普通外科杂志,2004,13(2):14-123.
DOI:10.7659/j. issn.1005-6947.2004.02.014

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2004-02-25